Table 2.
Inflammation and platelet biomarkers in the total group of ACS patients (STEMI, NSTEMI, and UA) compared to the controls. Results are presented as medians and interquartile ranges.
| ACS | C | P | |
|---|---|---|---|
| N = 93 | N = 30 | ||
| WBC [x103/μL] | 8.20 (6.70–10.1) | 6.31 (5.38–7.35) | 0.0000 |
| CRP [mg/L] | 2.1 (0.9–4.2) | 0.75 (0.5–1.1) | 0.0000 |
| IL-6 [pg/mL] | 12.0 (5.5–17.6) | 7.6 (6.9–8.1) | 0.0009 |
| PLT [x103/μL] | 217 (179–243) | 233 (207–250) | NS |
| MPV [fL] | 11.0 (10.1–11.3) | 9.4 (9.2–9.8) | 0.0000 |
| β-TG [IU/mL] | 81 (53–101) | 29 (23–33) | 0.0000 |
WBC – white blood cells count, CRP – C-reactive protein, IL-6 – interleukin-6, PLT – platelet count, MPV – mean platelet volume, L-PLT – large platelet, β-TG – β-thromboglobulin, STEMI – ST-segment elevation myocardial infarction, NSTEMI – non-ST-segment elevation myocardial infarction, UA – unstable angina.
Conversion factors to SI units are as follows: for WBC – 1.0, for PLT – 1.0.